Identification of Novel Targets for Cancer Therapy

Agendia AGENDIA B.V. Slotervaart Hospital Floor 9D Louwesweg 6 NL-1066 EC AMSTERDAM The Netherlands Phone: +31 20 512 9161 Fax: +31 20 512 9162 E-Mail: info@agendia.com Homepage: http://www.agendia.com

Specific aims of the project

Generation of prognostic gene expression signatures in three types of human cancer

Background of the group

Agendia focuses on the development of new prognostic tools, based on gene expression profiling, to be used in oncology. The company has its roots in the Netherlands Cancer Institute / Antoni van Leeuwenhoek hospital (NKI-AVL) in Amsterdam, The Netherlands, an internationally renowned cancer research center. Agendia's first product is MammaPrint®, a gene expression profiling service to assess the risk of recurrence in breast cancer patients. Through MammaPrint® and future products, Agendia wants to enable cancer patients to benefit immediately from the latest scientific findings in cancer research.

References

van 't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A. A. M., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M. J., Witteveen, A.T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. (2002).
Gene expression profiling predicts clinical outcome of breast cancer.
Nature 415, 530-536.

Van de Vijver, M.J., He, Y.D., van 't Veer, L.J., Dai, H., A M Hart, A.A.M., Voskuil, D., Schreiber, G.J., Peterse, J.L., Roberts, C., Marton, M.J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers,E. Th., Friend, S.H. and Bernards, R.. (2002).
A gene expression signature as a predictor of survival in breast cancer.
New England J. Med. 347, 1999-2009.

Bernards, R. and Weinberg, R.A. (2002).
Metastasis genes: A progression puzzle.
Nature, 418, 823.

Weigelt, B., Glas, A. M., Wessels, L. F., Witteveen, A. T., Peterse, J. L., van't Veer, L. J. (2003).
Gene expression profiles of primary breast tumors maintained in distant metastases.
Proc Natl Acad Sci U S A, 100, 15901-5.

Glas, A.M., Kersten, M.J., Delahaye, L.J.M.J., Witteveen, A.T., Kibbelaar, R.E., Velds, A., Wessels, L.F.A., Joosten, P., Kerkhoven, R.M., Bernards, R., van Krieken, J.H.J.M., Kluin, P.M., van 't Veer, L.J., de Jong, D. (2004).
Gene expression profiling in Follicular Lymphoma to assess clinical aggresiveness and to guide the choice of treatment.
Blood, Epub ahead of print.